Related Experiment Video
Updated: Aug 5, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
Atherosclerosis, cigarette smoking, and endogenous fibrinolysis: is there a direct link?
1Department of Cardiology, Royal Infirmary of Edinburgh, Lauriston Place, Edinburgh EH3 9YW, United Kingdom. schia@ed.ac.uk
Insights
Atherosclerosis and smoking impair the body's ability to release tissue plasminogen activator (tPA), a key factor in dissolving blood clots. This reduction in tPA may explain how these conditions worsen coronary artery disease complications.
Area of Science:
- Cardiovascular Science
- Thrombosis and Hemostasis
- Endothelial Biology
Background:
- Acute myocardial infarction results from coronary artery blockage by blood clots.
- Endothelial function and tissue plasminogen activator (tPA) are crucial for maintaining blood flow.
- Atherosclerosis and smoking are linked to endothelial dysfunction.
Purpose of the Study:
- To investigate the impact of atherosclerosis and cigarette smoking on endogenous fibrinolytic activity.
- To explore the role of impaired tPA release in the pathogenesis of coronary artery disease.
Main Methods:
- The study focuses on the physiological mechanisms underlying acute myocardial infarction.
- It examines the relationship between endothelial function, tPA release, and thrombotic complications.
- The research analyzes how atherosclerosis and smoking affect local fibrinolytic capacity.
Main Results:
- Atherosclerosis and cigarette smoking are associated with impaired endothelial function.
- These conditions appear to reduce the acute, local release of endogenous tissue plasminogen activator (tPA).
- Reduced tPA capacity may contribute to the initiation and progression of thrombotic events in coronary artery disease.
Conclusions:
- Impaired endothelial release of tPA due to atherosclerosis and smoking is a significant factor in coronary artery disease.
- This mechanism highlights how these risk factors can exacerbate acute and chronic thrombotic complications.
- Restoring or enhancing tPA function could be a therapeutic target for managing coronary artery disease.
Abstract:
Acute myocardial infarction is caused by thrombotic occlusion of a coronary artery at the site of a ruptured or eroded atheromatous plaque. The maintenance and regulation of tissue perfusion critically depend upon the integrity of endothelial function and the release of potent endothelium-derived factors, such as the fibrinolytic factor tissue plasminogen activator (tPA). Atherosclerosis and cigarette smoking are associated with dysfunction of the endothelium, and in particular, appear to impair the acute local endogenous fibrinolytic activity. This provides a potential mechanism whereby atherosclerosis and cigarette smoking can markedly influence the initiation, propagation, and resolution of the acute and chronic thrombotic complications of coronary artery disease through reductions in the capacity to release tPA acutely.
Related Concept Videos
Clot Retraction and Fibrinolysis
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Atherosclerosis I: Introduction
Atherosclerosis III: Management
Peripheral Artery Disease I: Introduction

